Harvard Bioscience
HBIO
HBIO
62 hedge funds and large institutions have $11.7M invested in Harvard Bioscience in 2025 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 21 increasing their positions, 16 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3% more funds holding
Funds holding: 60 → 62 (+2)
1.83% more ownership
Funds ownership: 37.34% → 39.16% (+1.8%)
Holders
62
Holding in Top 10
–
Calls
$67K
Puts
$5K
Top Buyers
| 1 | +$598K | |
| 2 | +$417K | |
| 3 | +$377K | |
| 4 |
Two Sigma Investments
New York
|
+$319K |
| 5 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
+$243K |
Top Sellers
| 1 | -$899K | |
| 2 | -$278K | |
| 3 | -$265K | |
| 4 |
AI
Acuitas Investments
Seattle,
Washington
|
-$215K |
| 5 |
PPW
Pasadena Private Wealth
Pasadena,
California
|
-$118K |
